docetaxel anhydrous has been researched along with amrubicin in 3 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (amrubicin) | Trials (amrubicin) | Recent Studies (post-2010) (amrubicin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 230 | 76 | 112 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hida, T; Ito, H; Kozaki, K; Matsuo, K; Miyaishi, O; Ogawa, M; Sugiura, T; Suzuki, T; Takahashi, T; Tatematsu, Y | 1 |
| Chikamori, K; Fukuoka, M; Harada, M; Harada, T; Horio, H; Iwamoto, Y; Katakami, N; Kitagawa, H; Kudoh, S; Masuda, N; Nakagawa, K; Nogami, N; Okamoto, H; Saito, H; Saka, H; Seto, T; Sunaga, N; Takahashi, T; Takeda, K; Tanaka, H; Yamamoto, N; Yamanaka, T; Yoshioka, H | 1 |
| Belevich, YV; Dygai, AM; Goldberg, AV; Goldberg, VE; Miroshnichenko, LA; Polyakova, TY; Popova, NO; Simanina, EV; Simolina, EI; Tuzikova, TP; Udut, EV; Vysotskaya, VV; Zhdanov, VV; Zyuz'kov, GN | 1 |
1 trial(s) available for docetaxel anhydrous and amrubicin
| Article | Year |
|---|---|
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer.
Topics: Aged; Anthracyclines; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Small Cell Lung Carcinoma; Taxoids; Treatment Outcome | 2017 |
2 other study(ies) available for docetaxel anhydrous and amrubicin
| Article | Year |
|---|---|
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
Topics: Adenocarcinoma; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Oxazoles; Paclitaxel; Prostaglandin-Endoperoxide Synthases; Taxoids; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2002 |
Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma.
Topics: Anthracyclines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disaccharides; Docetaxel; Doxorubicin; Erythropoiesis; Granulocytes; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Macrolides; Nitrosourea Compounds; Organoplatinum Compounds; Taxoids | 2017 |